SCHEMBL6985993

SCHEMBL6985993

CCCCS(=O)(=O)N(CC(=O)OCC)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 4/20 0.46
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
TP53 P04637 1/20 0.37
KDM1A O60341 2/20 0.37
POLB P06746 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NLRP3 Q96P20 1/20 0.36
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP14 P54578 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405916 0.88 NR3C1 (0.46) NR3C1GAAMAPTPDK1PDK2
Iodide SCHEMBL7949045 0.88 NR3C1 (0.46) NR3C1GAAMAPTPDK1PDK2
SCHEMBL6987763 0.87 NR3C1 (0.47) NR3C1GAAMAPTKDM1APOLB
SCHEMBL6986000 0.85 NR3C1 (0.36) NR3C1GAAMAPTPDK1PDK2
SCHEMBL6982684 0.81 KDM1A (0.43) NR3C1MAPTPDK1PDK2PDK3
SCHEMBL7407618 0.81 ALDH1A1 (0.44) NR3C1GAAMAPTKDM1AALDH1A1
SCHEMBL7958945 0.80 PDK1 (0.41) NR3C1GAAMAPTPDK1PDK2
SCHEMBL6982826 0.80 P2RX7 (0.41) NR3C1GAAMAPTKDM1A
SCHEMBL6985390 0.79 ALDH1A1 (0.40) NR3C1MAPTPDK1PDK2PDK3
SCHEMBL6985609 0.79 NOTUM (0.39) NR3C1GAAMAPTPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed